What is BoroPharm?
BoroPharm operates as a US-based entity specializing in the development and manufacturing of specialty chemicals. The company is dedicated to providing reliable, chemistry-based solutions across the entire production lifecycle, addressing customer needs in process development, procurement, and commercial supply chain management. BoroPharm's core competency lies in its chemical development capabilities, which have consistently delivered innovative and reproducible solutions for both development and commercial production requirements. The company emphasizes a results-oriented approach, aiming for cost-effectiveness, reproducibility, adherence to specifications, and timely delivery, thereby offering supply chain peace of mind to its clientele.
How much funding has BoroPharm raised?
BoroPharm has raised a total of $107K across 1 funding round:
Debt
$107K
Debt (2021): $107K with participation from PPP
What's next for BoroPharm?
The recent large-scale, late-stage funding, characterized as a major strategic investment, positions BoroPharm for accelerated expansion and market penetration. This capital infusion is expected to bolster its manufacturing capacity, enhance research and development initiatives, and potentially facilitate strategic partnerships or acquisitions. As a company focused on delivering value-added solutions in the specialty chemical sector, BoroPharm is poised to leverage this financial backing to solidify its competitive advantage and scale its operations to meet growing market demands.
See full BoroPharm company page
